These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 11604353)

  • 21. [Ex vivo expansion of hematopoietic stem cells: concept and clinical benefit].
    Ivanovic Z; Boiron JM
    Transfus Clin Biol; 2009; 16(5-6):489-500. PubMed ID: 19932632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity.
    Boiron JM; Dazey B; Cailliot C; Launay B; Attal M; Mazurier F; McNiece IK; Ivanovic Z; Caraux J; Marit G; Reiffers J
    Transfusion; 2006 Nov; 46(11):1934-42. PubMed ID: 17076849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The use of peripheral blood progenitor cells as an autologous hematopoietic support in high-dose chemotherapy. I. The rationale and results].
    Silva MR; Passos-Coelho JL; da Costa FL; Machado MA; Miranda N; Miranda MH; Parreira A
    Acta Med Port; 1999; 12(7-11):265-73. PubMed ID: 10707464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of recombinant hematopoietic growth factors in autologous bone marrow transplantation and peripheral blood stem cell transplantation].
    Hołowiecki J
    Acta Haematol Pol; 1994; 25(2 Suppl 1):95-103. PubMed ID: 8067214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Novel autograft method using positive selection of CD34 stem cells].
    Lambermont M; Pradier O; Delville JP; Quinet C; Bastin G; Marblie S; Capel P; Dupont E; Le Moine F; Gangji D
    Rev Med Brux; 1995 Nov; 16(5):372, 375-8. PubMed ID: 7501915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral blood stem cell transplantations: past, present and future.
    Hénon PR
    Stem Cells; 1993 May; 11(3):154-72. PubMed ID: 8100462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
    Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
    Lorenzon D; Mazzucato M; Abbruzzese L; Cilli M; De Angeli S; Degan M; Mambrini G; Piccardi F; Rupolo M; Michieli M; De Marco L; Gattei V; Astori G
    Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cell selection--clinical experience.
    Berenson RJ; Bensinger WI; Hill R; Andrews RG; Garcia-Lopez J; Kalamasz DF; Still BJ; Buckner CD; Bernstein ID; Thomas ED
    Prog Clin Biol Res; 1990; 333():403-10; discussion 411-3. PubMed ID: 1689855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy.
    Blystad AK; Delabie J; Kvaløy S; Holte H; Vålerhaugen H; Ikonomou I; Kvalheim G
    Br J Haematol; 2004 Jun; 125(5):605-12. PubMed ID: 15147376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical applications of ex vivo cultured CD34+ cells and myeloid progenitors.
    Zimmerman TM; Williams SF
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):257-64. PubMed ID: 10068059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of peripheral blood progenitor cells as an autologous hematopoietic support in high-dose chemotherapy. II. The experience of the Hematological Intensive Care Unit of the IPOFG. Franciso Gentil Portuguese Institute of Oncology].
    Silva MR; Passos-Coelho JL; da Costa FL; Machado MA; Miranda N; Miranda MH; Parreira A
    Acta Med Port; 1999; 12(7-11):275-81. PubMed ID: 10707465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].
    Michallet M; Dhedin N; Michallet AS
    Bull Cancer; 2001 Sep; 88(9):908-26. PubMed ID: 11604365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ex vivo procedures associated with autologous hematopoietic stem cell transplantation].
    Fernández M; Minguell JJ
    Rev Med Chil; 1994 Jun; 122(6):699-704. PubMed ID: 7732217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technology evaluation: Stem-cell therapy, Aastrom Biosciences Inc.
    Morse MA
    Curr Opin Mol Ther; 1999 Dec; 1(6):745-52. PubMed ID: 19629872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL.
    Flohr T; Hess G; Kolbe K; Gamm H; Nolte H; Stanislawski T; Huber C; Derigs HG
    Bone Marrow Transplant; 2002 May; 29(9):769-75. PubMed ID: 12040475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Autologous peripheral blood stem cells mobilization with etoposide plus rhG-CSF versus cyclophosphamide plus rhG-CSF].
    Shi YK; He XH; Han XH; Liu P; Yang JL; Zhou SY; Zhou AP; Zhang CG; Ai B
    Ai Zheng; 2003 Dec; 22(12):1311-6. PubMed ID: 14693058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem cell purging: an intriguing dilemma.
    Rizzoli V; Carlo-Stella C
    Exp Hematol; 1995 Apr; 23(4):296-302. PubMed ID: 7895779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New developments in stem cell detection and stem cell selection in the context of autologous transplantations.
    Douay L; Lopez M; Giarratana MC; Bony V; Bouchet S; Gorin NC
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):87-9. PubMed ID: 8099734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.